secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K/A
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001140361-23-045249
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Dorothy J. Clarke appointed to all three committees of Eterna Therapeutics Board
--------------------------------------------------------------------------------

- Dorothy J. Clarke appointed to Audit Committee, Compensation Committee, and Nominating and Governance Committee.
- Appointment effective September 23, 2023; committee roles are immediate.
- Clarke joined the Board on August 28, 2023, for term through 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/0001140361-23-045249-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/ef20011289_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-045249

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer